TNF‐α‐mediated reduction in PGC‐1α may impair skeletal muscle function after cigarette smoke exposure
暂无分享,去创建一个
[1] Y. Hellsten,et al. PGC-1alpha mediates exercise-induced skeletal muscle VEGF expression in mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[2] H. Pilegaard,et al. The role of PGC-1alpha on mitochondrial function and apoptotic susceptibility in muscle. , 2009, American journal of physiology. Cell physiology.
[3] M. Polkey,et al. Altered Body Composition and Muscle Anabolic, Catabolic and Metabolic Gene Expression in COPD Patients with Elevated Skeletal Muscle Inflammation. , 2009, ATS 2009.
[4] M. Tisdale. Mechanisms of cancer cachexia. , 2009, Physiological reviews.
[5] G. Joos,et al. Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure. , 2009, American journal of respiratory cell and molecular biology.
[6] D. Taillandier,et al. Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia , 2008, Current opinion in supportive and palliative care.
[7] W. Mizunoya,et al. Protocol for high-resolution separation of rodent myosin heavy chain isoforms in a mini-gel electrophoresis system. , 2008, Analytical biochemistry.
[8] A. Musarò,et al. Measuring Mechanical Properties, Including Isotonic Fatigue, of Fast and Slow MLC/mIgf-1 Transgenic Skeletal Muscle , 2008, Annals of Biomedical Engineering.
[9] B. Spiegelman,et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α , 2008, Nature.
[10] B. Spiegelman,et al. Skeletal Muscle Fiber-type Switching, Exercise Intolerance, and Myopathy in PGC-1α Muscle-specific Knock-out Animals* , 2007, Journal of Biological Chemistry.
[11] M. Polkey,et al. Cytokine profile in quadriceps muscles of patients with severe COPD , 2007, Thorax.
[12] P. Schrauwen,et al. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD , 2007, European Respiratory Journal.
[13] Jiandie D. Lin,et al. PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.
[14] K. Myburgh,et al. Electrophoretic separation of human skeletal muscle myosin heavy chain isoforms: the importance of reducing agents. , 2006, The journal of physiological sciences : JPS.
[15] M. Morris,et al. Cigarette smoke exposure reprograms the hypothalamic neuropeptide Y axis to promote weight loss. , 2006, American journal of respiratory and critical care medicine.
[16] S. Bozinovski,et al. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease). , 2006, Pharmacology & therapeutics.
[17] E. Wouters,et al. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. , 2006, American journal of respiratory cell and molecular biology.
[18] Jiandie D. Lin,et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. , 2005, Cell metabolism.
[19] K. Tang,et al. Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. , 2004, Physiological genomics.
[20] P. Barnes,et al. New concepts in chronic obstructive pulmonary disease. , 2003, Annual review of medicine.
[21] F. Booth,et al. Molecular regulation of individual skeletal muscle fibre types. , 2003, Acta physiologica Scandinavica.
[22] Jiandie D. Lin,et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres , 2002, Nature.
[23] Jiandie D. Lin,et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. , 2002, Nature.
[24] J. Barberà,et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[25] H. Saito,et al. The Relationship between Chronic Hypoxemia and Activation of the Tumor Necrosis Factor- α System in Patients with Chronic Obstructive Pulmonary Disease , 2000 .
[26] H. Saito,et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[27] E. Wouters,et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[28] Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. , 1998, Journal of cardiopulmonary rehabilitation.
[29] F. Maltais,et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. , 1998, Medicine and science in sports and exercise.
[30] F. Maltais,et al. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. , 1998, Journal of applied physiology.
[31] S. Shapiro,et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.
[32] E. Wouters,et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.
[33] P. Wagner,et al. Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. , 1996, Journal of applied physiology.
[34] J. Mege,et al. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.
[35] A. Benabid,et al. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. , 1992, The European respiratory journal.
[36] A. Churg,et al. Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig. , 1990, The American review of respiratory disease.
[37] M. Grim,et al. Enzymatic heterogeneity of the capillary bed of rat skeletal muscles. , 1986, The American journal of anatomy.
[38] M. Danson,et al. Citrate synthase. , 2020, Current topics in cellular regulation.
[39] P. Srere,et al. [1] Citrate synthase. [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)] , 1969 .